Last reviewed · How we verify

Winuf® peri — Competitive Intelligence Brief

Winuf® peri (Winuf® peri) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: SSRI. Area: Psychiatry.

marketed SSRI Serotonin transporter Psychiatry Small molecule Live · refreshed every 30 min

Target snapshot

Winuf® peri (Winuf® peri) — Chonbuk National University Hospital. Winuf peri is a selective serotonin reuptake inhibitor (SSRI) that works by increasing the levels of serotonin in the brain.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Winuf® peri TARGET Winuf® peri Chonbuk National University Hospital marketed SSRI Serotonin transporter
Trintellix vortioxetine Takeda marketed Serotonin modulator and stimulator (SMS); SSRI-like agent Serotonin transporter (SERT); 5-HT3 receptor; 5-HT1A receptor 2013-01-01
Fetzima LEVOMILNACIPRAN AbbVie marketed Serotonin and Norepinephrine Reuptake Inhibitor Sodium-dependent serotonin transporter 2013-01-01
Pristiq desvenlafaxine Alembic Pharms Ltd marketed Serotonin and Norepinephrine Reuptake Inhibitor Sodium-dependent serotonin transporter 2008-01-01
Celexa CITALOPRAM AbbVie marketed Serotonin Reuptake Inhibitor Sodium-dependent serotonin transporter 1998-01-01
Plavix clopidogrel Generic (originally Sanofi/BMS) marketed Thienopyridine antiplatelet agent Cytochrome P450 2B6, P2Y purinoceptor 12, Sodium-dependent serotonin transporter 1997-11-17
Racemic Sibutramine SIBUTRAMINE marketed Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic Sodium-dependent serotonin transporter 1997-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (SSRI class)

  1. Washington University School of Medicine · 2 drugs in this class
  2. Astellas Pharma Inc · 1 drug in this class
  3. Beni-Suef University · 1 drug in this class
  4. Bristol-Myers Squibb · 1 drug in this class
  5. Centre of Clinical Pharmacology, Hanoi Medical University · 1 drug in this class
  6. Chonbuk National University Hospital · 1 drug in this class
  7. EMS · 1 drug in this class
  8. Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · 1 drug in this class
  9. PMG Pharm Co., Ltd · 1 drug in this class
  10. PT Bio Farma · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Winuf® peri — Competitive Intelligence Brief. https://druglandscape.com/ci/winuf-peri. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: